Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Covalon to showcase IV Clear to pediatric specialists at AVA annual meeting

Covalon Technologies announced that it will be presenting the latest version of IV Clear at the Association for Vascular Access (AVA) Annual Scientific Meeting.

In addition to the main event, Covalon will be one of a limited number of industry participants at the AVA Pediatric Special Interest Group’s pre-meeting educational workshop.

IV Clear is the only dual antimicrobial clear silicone adhesive securement dressing that protects patients from bacteria and yeast, while also protecting them from unnecessary skin damage commonly found with the use of other vascular access dressings.

AVA's Annual Scientific Meeting is the premier event dedicated to scientific research and clinical best practices within vascular access and will be held from September 16 to September 19, 2016.

The annual meeting provides Covalon the opportunity to engage in educational sessions, professional development roundtables, hands-on clinical training, new product demonstrations, and networking with over 1,400 vascular access professionals.

“This year’s AVA meeting will provide Covalon with a platform to introduce the advancements made with IV Clear to leading vascular access professionals,” said Brian Pedlar, Covalon’s Chief Executive Officer.

“AVA provides us a convenient forum to personally connect with the clinicians in the United States that use IV Clear every day on pediatric, oncology and sensitive skin patients who require antimicrobial protection along with vascular catheter insertions.

Our recent victory with IV Clear being selected as the exclusive antimicrobial vascular access dressing in Saudi Arabia Ministry of Health hospitals and clinics provides a good reference point for Covalon to expand the use of IV Clear on any patient with a vascular catheter or other percutaneous device inserted through their skin.”

IV Clear™ is indicated to cover and protect vascular access devices used in a wide variety of both acute and alternate care settings.

Its patented combination of chlorhexidine and silver is proven to have a synergistic effect against some of the most commonly associated blood stream infection bacteria1 and its skin sparing silicone adhesive will not cause adhesive related skin injury or pain during dressing changes2.

The Association for Vascular Access is an association of healthcare professionals founded in 1985 to promote the emerging vascular access specialty.